FDA Inspection
NW CryobankNW Cryobank – FDA Inspection, Jan 29, 2013
Record Details
This FDA Inspection record concerns NW Cryobank, with an inspection on January 29, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- NW Cryobank
- Inspection Date
- January 29, 2013
- Product Type
- Biologics
View Company Profile
ID · 868a8640-1c83-46bf-b58b-50a6b94352d9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 816634
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 1271.55(d)(2)Accurate, indelible, legible
- 21 CFR 1271.47(a)Procedures for all other requirements
- 21 CFR 1271.75(e)Abbreviated procedure
Full citation text and observation details available on the Dashboard.
Other FDA inspections of NW Cryobank
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 27, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 12, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 27, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for NW Cryobank
- FDA Inspection 1098180 - 2019-06-27
- FDA Inspection 983345 - 2016-09-12
- FDA Inspection 893021 - 2014-08-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.